The low-carbon technologies to help avert climate change are there, but they need to be deployed, say some of the world’s best-known electricity companies.
Investing in innovation during a tight economy could provide a leg up for funders and start-ups once the turnaround comes, a Science|Business conference heard.
Cancer Research UK (CRUK) launched a five-year plan which will see the charity spend around GBP 300 million a year on core areas of science in a bid to reduce cancer deaths, including greater investment in cancers where survival rates are poor.
David Alcock of the Patent Attorneys D Young & Co addresses concerns that a recent patent judgment undermines the concept of evergreening, even though Tate & Lyle’s US patents to Sucralose are valid.
A study commissioned by three of the UK’s leading scientific institutions has demonstrated substantial financial and social benefits from investment in medical research.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.